Work

Fucoidan and Hyaluronic Acid Modified ZE21B Magnesium Alloy for Better Hemocompatibility and Vascular Cell Response

Year: 2025
Type: article
Abstract: Magnesium alloy stents have great potential for the treatment of cardiovascular and cerebrovascular diseases due to their excellent mechanical supportability and biodegradability. However, bare magnesium alloy stents often degrade too rapidly and demonstrate insufficient biocompatibility, severely limiting their clinical applicability. Herein, a composite coating consisting of MgF2 conversion layer, polydopamine (PDA) layer, fucoidan, and hyaluronic acid was prepared to enhance the corrosion resistance and biocompatibility of ZE21B alloy for vascular stent application. The modified ZE21B alloy exhibited relatively high surface roughness, moderate wettability, and better corrosion resistance. Moreover, the modified ZE21B alloy with low hemolysis rate and fibrinogen adsorption level confirmed improved hemocompatibility for medical requirements. Furthermore, the ZE21B alloy modified with fucoidan and hyaluronic acid could promote the adhesion, proliferation, and NO release of ECs, and meanwhile inhibit the adhesion and proliferation of SMCs and promote the competitive growth of ECs over SMCs due to the synergistic effect of natural fucoidan and hyaluronic acid. The modification with fucoidan and hyaluronic acid significantly enhanced the corrosion resistance and biocompatibility of ZE21B magnesium alloy, thereby providing a simple and effective strategies for the development of biodegradable vascular stents.
Source: Coatings
Language: English
Subfield: Biomaterials
Open Access status: gold
Estimated APC paid: $3,137
OpenAlex ID: W4411453041
FWCI: 0.374
Cites: 36
Cited by: 2
Related to: 10